DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $297,000 | -37.6% | 1,172 | -27.7% | 0.22% | +107.4% |
| Q1 2022 | $476,000 | -12.5% | 1,622 | -1.8% | 0.11% | -6.1% |
| Q4 2021 | $544,000 | +3.6% | 1,651 | -4.2% | 0.12% | -2.5% |
| Q3 2021 | $525,000 | +18.0% | 1,724 | +4.0% | 0.12% | +16.8% |
| Q2 2021 | $445,000 | +24.3% | 1,658 | +4.4% | 0.10% | +13.5% |
| Q1 2021 | $358,000 | -61.4% | 1,588 | -61.9% | 0.09% | -48.0% |
| Q4 2020 | $928,000 | +5.2% | 4,172 | +1.9% | 0.17% | -7.6% |
| Q3 2020 | $882,000 | +20.8% | 4,093 | -0.7% | 0.18% | +17.1% |
| Q2 2020 | $730,000 | +34.2% | 4,122 | +5.0% | 0.16% | +12.1% |
| Q1 2020 | $544,000 | +25.6% | 3,925 | +39.0% | 0.14% | +53.3% |
| Q4 2019 | $433,000 | +14.6% | 2,823 | +7.9% | 0.09% | +37.3% |
| Q3 2019 | $378,000 | +186.4% | 2,616 | +95.2% | 0.07% | +123.3% |
| Q2 2019 | $132,000 | -64.4% | 1,340 | -52.3% | 0.03% | -57.7% |
| Q1 2019 | $371,000 | +74.2% | 2,809 | +36.4% | 0.07% | +54.3% |
| Q4 2018 | $213,000 | +22.4% | 2,060 | +28.2% | 0.05% | +31.4% |
| Q3 2018 | $174,000 | +13.0% | 1,607 | +2.9% | 0.04% | +6.1% |
| Q2 2018 | $154,000 | -9.9% | 1,562 | -10.4% | 0.03% | -13.2% |
| Q1 2018 | $171,000 | +69.3% | 1,744 | +60.4% | 0.04% | +58.3% |
| Q4 2017 | $101,000 | – | 1,087 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |